shanghaigenomics Management Team

	Ying Luo, Ph.D., Chairman,President and CEO Dr. Luo is the cofounder of Shanghai Genomics and GNI's Chairman,President and CEO. An accomplished entrepreneur and scientist with over 20 years of experience in biomedical research he conducted research in area of protein-protein interactions and their related genomics, and he has authored many publications in the top scientific journals. Before founding Shanghai Genomics, he gained experience at Aviron and Clontech, both US bioventure firms, before joining Rigel Pharmaceuticals, where he served as the senior director of Genomics and Target Discovery. Prior to that, in 1993 he joined the University of California San Francisco as a postdoctoral fellow studying HIV. Dr. Luo is currently also a director of functional genomics at the Chinese National Genome Center at Shanghai and an adjunct professor at Shanghai Jiaotong University. He completed his undergraduate education at Peking Union Medical College (Peking University) in 1982 and received his doctorate in biomedical science from the University of Connecticut Health Center in 1991.
	Yuwen Wu, VP,Chief Financial Officer As a Senior Accountant and Senior Certified International Finance Manager, Ms. Wu graduated from Shanghai University of Finance and Economics.She has been supervising the Department of Finance and Accounting from 2001. She had held various positions of finance and investment affairs, at Dengfeng Electronic Technology Co. and Shanghai Zhangjiang Hi-Tech Park Development Co. Her responsibilities covered accounting, finance management, controlling, budget management and investment analysis, etc. She is also familiar with international accounting standards and financial reporting system.
	Wenjun Chen, VP Dr. Wenjun Chen, vice president of Shanghai Genomics, supervising the CRO business since 2010. He graduated in 2002 from Fudan University, majoring in chemistry and molecular biology and spent three years in Rutgers University, US in conducting his postdoctoral researches on MAPK signaling cascades. In 2006 he came back to China and joined Shanghai Genomics, leading and participating in biological research services as the manager and senior director. And in 2010, he was appointed as the vice president, supervising the CRO business in Shanghai Genomics, covering the area of gene cloning, protein generation, antibody production and cell biological services.